Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
The Cys2/His2-type zinc finger protein Zfp296 has been implicated in stem cell pluripotency and tumor pathogenesis.However, its mechanisms remain elusive.
|
28963472 |
2017 |
leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Thus, overexpression of ZNF342 by translocation or other mechanisms contributes to leukemia biology in multiple hematopoietic compartments.
|
19255975 |
2009 |
Acute lymphocytic leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Analysis of ZNF342 protein levels in a large dataset of leukemia samples by reverse phase protein array showed that higher levels of ZNF342 expression in acute lymphoblastic leukemia was associated with poorer outcome (P = 0.033).
|
19255975 |
2009 |
Acute monocytic leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In the myeloid leukemia samples with the highest ZNF342 expression, there was overrepresentation of FLT3 internal tandem duplication (P = 0.0016) and AML subtype M7 (P = 0.0002).
|
19255975 |
2009 |
Leukemia, Myelocytic, Acute
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In the myeloid leukemia samples with the highest ZNF342 expression, there was overrepresentation of FLT3 internal tandem duplication (P = 0.0016) and AML subtype M7 (P = 0.0002).
|
19255975 |
2009 |
Childhood Acute Myeloid Leukemia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Overexpression of ZNF342 by juxtaposition with MPO promoter/enhancer in the novel translocation t(17;19)(q23;q13.32) in pediatric acute myeloid leukemia and analysis of ZNF342 expression in leukemia.
|
19255975 |
2009 |
Childhood Leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Thus, overexpression of ZNF342 by translocation or other mechanisms contributes to leukemia biology in multiple hematopoietic compartments.
|
19255975 |
2009 |
Precursor Cell Lymphoblastic Leukemia Lymphoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Analysis of ZNF342 protein levels in a large dataset of leukemia samples by reverse phase protein array showed that higher levels of ZNF342 expression in acute lymphoblastic leukemia was associated with poorer outcome (P = 0.033).
|
19255975 |
2009 |
Glioma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
ZNF342 expression is specifically decreased in primary oligodendrogliomas and up-regulated in glioma cell lines treated with a demethylating agent, whereas the expression level of the adjacent gene, Gemin7, is not consistently altered in these samples.
|
14633674 |
2003 |
oligodendroglioma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
ZNF342 expression is specifically decreased in primary oligodendrogliomas and up-regulated in glioma cell lines treated with a demethylating agent, whereas the expression level of the adjacent gene, Gemin7, is not consistently altered in these samples.
|
14633674 |
2003 |
Well Differentiated Oligodendroglioma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
ZNF342 expression is specifically decreased in primary oligodendrogliomas and up-regulated in glioma cell lines treated with a demethylating agent, whereas the expression level of the adjacent gene, Gemin7, is not consistently altered in these samples.
|
14633674 |
2003 |